Charles River Laboratories International Inc
NYSE:CRL
Charles River Laboratories International Inc
Income from Continuing Operations
Charles River Laboratories International Inc
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Charles River Laboratories International Inc
NYSE:CRL
|
Income from Continuing Operations
$450.9m
|
CAGR 3-Years
6%
|
CAGR 5-Years
15%
|
CAGR 10-Years
15%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Income from Continuing Operations
$6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
Danaher Corp
NYSE:DHR
|
Income from Continuing Operations
$7.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
28%
|
CAGR 10-Years
12%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Income from Continuing Operations
$777.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
Agilent Technologies Inc
NYSE:A
|
Income from Continuing Operations
$1.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
1%
|
CAGR 10-Years
22%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Income from Continuing Operations
$1.4B
|
CAGR 3-Years
65%
|
CAGR 5-Years
42%
|
CAGR 10-Years
20%
|
See Also
What is Charles River Laboratories International Inc's Income from Continuing Operations?
Income from Continuing Operations
450.9m
USD
Based on the financial report for Mar 30, 2024, Charles River Laboratories International Inc's Income from Continuing Operations amounts to 450.9m USD.
What is Charles River Laboratories International Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
15%
Over the last year, the Income from Continuing Operations growth was -10%. The average annual Income from Continuing Operations growth rates for Charles River Laboratories International Inc have been 6% over the past three years , 15% over the past five years , and 15% over the past ten years .